Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.

Authors

Cia-Hin Lau
Sekaran Muniandy

Document Type

Article

Publication Date

1-1-2011

Abstract

The novel AR and IRAR indexes are cost-effective, precise, reproducible and reliable integrated diagnostic biomarkers of insulin sensitivity for screening subjects with increased risk of future development of T2DM and MS.

Keywords

Novel adiponectin-resistin (AR), insulin resistance (IRAR), diabetes

Publication Title

Cardiovascular Diabetology

Volume

10

Issue

1